📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19. (2024)

First Author: Bechman K

Attributed to: Urgent research and surveillance on Covid-19 using the new OpenSAFELY secure platform across 55 million patients' full linked primary care records funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2024.106227

PubMed Identifier: 39019401

Publication URI: http://europepmc.org/abstract/MED/39019401

Type: Journal Article/Review

Volume: 89

Parent Publication: The Journal of infection

Issue: 3

ISSN: 0163-4453